Stay updated on ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial.
Sign up to get notified when there's something new on the ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial. page.

Latest updates to the ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial. page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedA sitewide notice was added about NIH website updates, including a statement that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.7%

- Check21 days agoChange DetectedThe site footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1, while the study record history remains unchanged.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision label 'Revision: v3.7.0' was added to the Study Record Versions, and the older label 'Revision: v3.6.6' was removed. This indicates a platform/UI version update in the history display.SummaryDifference0.1%

- Check70 days agoChange DetectedThe study record history adds a new Revision: v3.6.6 entry and removes the previous Revision: v3.6.5, indicating a minor platform update to the history log.SummaryDifference0.1%

Stay in the know with updates to ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial. page.